<p>动态科技实验室私人有限公司在最近向证券交易委员会的披露中表示，在第二季度减少了对 Privia Health Group, Inc.（NASDAQ:PRVA - 免费报告）46.6% 的持股。该公司在出售了 23,970 股后，持有 27,426 股该公司的股票。动态科技实验室私人有限公司在 Privia Health Group 的持股在最近的报告期末价值为 631,000 美元。</p>
<p>其他一些对冲基金和机构投资者也对该股票的持仓进行了调整。US Bancorp DE 在第一季度将其在 Privia Health Group 的持仓提高了 2.4%。US Bancorp DE 现在拥有 18,487 股该公司的股票，价值 415,000 美元，此前在上个季度增持了 429 股。蒙特利尔银行在第二季度将其在 Privia Health Group 的持股提高了 1.9%。蒙特利尔银行现在拥有 28,694 股该公司的股票，价值 660,000 美元，此前在上个季度增持了 543 股。CWM LLC 在第一季度将其在 Privia Health Group 的持股提高了 50.3%。CWM LLC 现在拥有 1,804 股该公司的股票，价值 40,000 美元，此前在上个季度增持了 604 股。马里兰州退休与养老金系统在第二季度将其在 Privia Health Group 的持股提高了 2.5%。马里兰州退休与养老金系统现在拥有 30,814 股该公司的股票，价值 709,000 美元，此前在上个季度增持了 763 股。最后，MQS 管理有限公司在第二季度将其在 Privia Health Group 的持仓提高了 8.5%。MQS 管理有限公司现在拥有 10,167 股该公司的股票，价值 234,000 美元，此前在此期间增持了 795 股。目前 94.48% 的股票由机构投资者和对冲基金持有。</p>
<p>获取 <strong>Privia Health Group</strong> 的提醒：</p>
<h2>Privia Health Group 股价上涨 5.3%</h2>
<p>PRVA 的股票在周五开盘价为 23.74 美元。该公司的 50 日简单移动平均线为 24.21 美元，200 日简单移动平均线为 22.78 美元。Privia Health Group, Inc.的 1 年最低价为 18.77 美元，1 年最高价为 26.51 美元。该公司的市值为 29.2 亿美元，市盈率为 182.63，PEG 比率为 3.95，贝塔值为 0.83。</p>
<p>Privia Health Group（NASDAQ:PRVA - 获取免费报告）最近在 6 月 7 日（星期二）公布了季度财报。该公司报告季度每股收益为 0.10 美元。该季度的收入为 2.1361 亿美元。Privia Health Group 的净利润率为 0.89%，股本回报率为 2.52%。作为一个整体，研究分析师预测 Privia Health Group, Inc.在本年度将发布 0.14 美元的每股收益。</p>
<h2>华尔街分析师观点</h2>
<p>一些股票分析师对 PRVA 股票发表了看法。巴克莱将 Privia Health Group 的目标价从 22.00 美元上调至 23.00 美元，并在 11 月 10 日的研究报告中给予该股票 “持平” 评级。Truist Financial 在 11 月 10 日的报告中重申了 “买入” 评级，并将 Privia Health Group 的目标价设定为 31.00 美元（之前为 30.00 美元）。花旗集团在 8 月 29 日的研究报告中重申了对 Privia Health Group 的 “跑赢大盘” 评级。斯蒂芬斯在 9 月 24 日的研究报告中重申了 “增持” 评级，并对 Privia Health Group 的股票设定了 32.00 美元的目标价。最后，派珀·桑德勒在 8 月 11 日的报告中将 Privia Health Group 的目标价从 36.00 美元下调至 35.00 美元，并对该公司设定了 “增持” 评级。十三位研究分析师对该股票给予了买入评级，三位分析师给予了持有评级。根据 MarketBeat 的数据，Privia Health Group 目前的共识评级为 “适度买入”，平均目标价为 30.00 美元。</p>
<p><strong>查看我们关于 Privia Health Group 的最新股票报告</strong></p>
<h2>Privia Health Group 公司简介</h2>
<p>（免费报告）</p>
<p>Privia Health Group, Inc.在美国作为一家国家级的医生赋能公司运营。该公司与医疗集团、健康计划和健康系统合作，以优化医生实践、提升患者体验，并奖励医生在面对面和虚拟环境中提供护理。</p>
<h2>阅读更多</h2>
<ul>
<li>我们更看好的五只股票，胜过 Privia Health Group</li>
<li>在哪里找到财报电话会议记录</li>
<li>MP 材料公司在财报后股价飙升——真正原因在这里</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>为什么 Palantir 的下滑可能是长期机会的铺垫</li>
<li>股息贵族的最佳名单：通过贵族指数积累财富</li>
<li>收入投资者注意：这只 REIT 正在打折出售</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Privia Health Group 吗？</h2>
<p>在考虑 Privia Health Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Privia Health Group 并不在名单上。</p>
<p>虽然 Privia Health Group 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

PRVA

<p>动态科技实验室私人有限公司在第二季度减少了对 Privia Health Group, Inc.的持股比例，降幅为 46.6%，目前持有 27,426 股，价值 63.1 万美元。其他机构投资者也调整了他们的持仓。Privia Health Group 的股票上涨了 5.3%，市值为 29.2 亿美元。分析师对该股票给予了 “适度买入” 的共识评级，平均目标价为 30.00 美元</p>

<p>Dynamic Technology Lab Private Ltd lessened its stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 46.6% in the 2nd quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The firm owned 27,426 shares of the company's stock after selling 23,970 shares during the quarter. Dynamic Technology Lab Private Ltd's holdings in Privia Health Group were worth $631,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>动态科技实验室私人有限公司在最近向证券交易委员会的披露中表示，在第二季度减少了对 Privia Health Group, Inc.（NASDAQ:PRVA - 免费报告）46.6% 的持股。该公司在出售了 23,970 股后，持有 27,426 股该公司的股票。动态科技实验室私人有限公司在 Privia Health Group 的持股在最近的报告期末价值为 631,000 美元。</p>
</div><p>A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. US Bancorp DE lifted its position in Privia Health Group by 2.4% in the 1st quarter. US Bancorp DE now owns 18,487 shares of the company's stock valued at $415,000 after acquiring an additional 429 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of Privia Health Group by 1.9% in the second quarter. Bank of Montreal Can now owns 28,694 shares of the company's stock valued at $660,000 after purchasing an additional 543 shares in the last quarter. CWM LLC lifted its holdings in shares of Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after purchasing an additional 604 shares in the last quarter. Maryland State Retirement &amp; Pension System lifted its holdings in shares of Privia Health Group by 2.5% in the second quarter. Maryland State Retirement &amp; Pension System now owns 30,814 shares of the company's stock valued at $709,000 after purchasing an additional 763 shares in the last quarter. Finally, MQS Management LLC boosted its position in shares of Privia Health Group by 8.5% during the second quarter. MQS Management LLC now owns 10,167 shares of the company's stock worth $234,000 after buying an additional 795 shares during the period. 94.48% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者也对该股票的持仓进行了调整。US Bancorp DE 在第一季度将其在 Privia Health Group 的持仓提高了 2.4%。US Bancorp DE 现在拥有 18,487 股该公司的股票，价值 415,000 美元，此前在上个季度增持了 429 股。蒙特利尔银行在第二季度将其在 Privia Health Group 的持股提高了 1.9%。蒙特利尔银行现在拥有 28,694 股该公司的股票，价值 660,000 美元，此前在上个季度增持了 543 股。CWM LLC 在第一季度将其在 Privia Health Group 的持股提高了 50.3%。CWM LLC 现在拥有 1,804 股该公司的股票，价值 40,000 美元，此前在上个季度增持了 604 股。马里兰州退休与养老金系统在第二季度将其在 Privia Health Group 的持股提高了 2.5%。马里兰州退休与养老金系统现在拥有 30,814 股该公司的股票，价值 709,000 美元，此前在上个季度增持了 763 股。最后，MQS 管理有限公司在第二季度将其在 Privia Health Group 的持仓提高了 8.5%。MQS 管理有限公司现在拥有 10,167 股该公司的股票，价值 234,000 美元，此前在此期间增持了 795 股。目前 94.48% 的股票由机构投资者和对冲基金持有。</p>
</div><p>Get <strong>Privia Health Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Privia Health Group</strong> 的提醒：</p>
</div><h2>Privia Health Group Trading Up 5.3%</h2>
<div class="lb-trans"><h2>Privia Health Group 股价上涨 5.3%</h2>
</div><p>Shares of PRVA opened at $23.74 on Friday. The company's fifty day simple moving average is $24.21 and its 200 day simple moving average is $22.78. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51. The company has a market cap of $2.92 billion, a price-to-earnings ratio of 182.63, a PEG ratio of 3.95 and a beta of 0.83.</p>
<div class="lb-trans"><p>PRVA 的股票在周五开盘价为 23.74 美元。该公司的 50 日简单移动平均线为 24.21 美元，200 日简单移动平均线为 22.78 美元。Privia Health Group, Inc.的 1 年最低价为 18.77 美元，1 年最高价为 26.51 美元。该公司的市值为 29.2 亿美元，市盈率为 182.63，PEG 比率为 3.95，贝塔值为 0.83。</p>
</div><p>Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. As a group, research analysts forecast that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.</p>
<div class="lb-trans"><p>Privia Health Group（NASDAQ:PRVA - 获取免费报告）最近在 6 月 7 日（星期二）公布了季度财报。该公司报告季度每股收益为 0.10 美元。该季度的收入为 2.1361 亿美元。Privia Health Group 的净利润率为 0.89%，股本回报率为 2.52%。作为一个整体，研究分析师预测 Privia Health Group, Inc.在本年度将发布 0.14 美元的每股收益。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of equities analysts have weighed in on PRVA shares. Barclays upped their price target on Privia Health Group from $22.00 to $23.00 and gave the stock an &#34;equal weight&#34; rating in a research report on Monday, November 10th. Truist Financial restated a &#34;buy&#34; rating and set a $31.00 target price (up previously from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Citigroup reaffirmed an &#34;outperform&#34; rating on shares of Privia Health Group in a research report on Friday, August 29th. Stephens reiterated an &#34;overweight&#34; rating and issued a $32.00 price target on shares of Privia Health Group in a research note on Wednesday, September 24th. Finally, Piper Sandler decreased their price objective on Privia Health Group from $36.00 to $35.00 and set an &#34;overweight&#34; rating for the company in a report on Monday, August 11th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to MarketBeat, Privia Health Group currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $30.00.</p>
<div class="lb-trans"><p>一些股票分析师对 PRVA 股票发表了看法。巴克莱将 Privia Health Group 的目标价从 22.00 美元上调至 23.00 美元，并在 11 月 10 日的研究报告中给予该股票 “持平” 评级。Truist Financial 在 11 月 10 日的报告中重申了 “买入” 评级，并将 Privia Health Group 的目标价设定为 31.00 美元（之前为 30.00 美元）。花旗集团在 8 月 29 日的研究报告中重申了对 Privia Health Group 的 “跑赢大盘” 评级。斯蒂芬斯在 9 月 24 日的研究报告中重申了 “增持” 评级，并对 Privia Health Group 的股票设定了 32.00 美元的目标价。最后，派珀·桑德勒在 8 月 11 日的报告中将 Privia Health Group 的目标价从 36.00 美元下调至 35.00 美元，并对该公司设定了 “增持” 评级。十三位研究分析师对该股票给予了买入评级，三位分析师给予了持有评级。根据 MarketBeat 的数据，Privia Health Group 目前的共识评级为 “适度买入”，平均目标价为 30.00 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on Privia Health Group</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Privia Health Group 的最新股票报告</strong></p>
</div><h2>Privia Health Group Company Profile</h2>
<div class="lb-trans"><h2>Privia Health Group 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.</p>
<div class="lb-trans"><p>Privia Health Group, Inc.在美国作为一家国家级的医生赋能公司运营。该公司与医疗集团、健康计划和健康系统合作，以优化医生实践、提升患者体验，并奖励医生在面对面和虚拟环境中提供护理。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Privia Health Group</li>
<li>Where to Find Earnings Call Transcripts</li>
<li>MP Materials Stock Soared After Earnings—Here’s the Real Reason</li>
<li>Earnings Per Share Calculator: How to Calculate EPS</li>
<li>Why Palantir Slide May Be a Setup for a Long-Term Opportunity</li>
<li>Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index</li>
<li>Attention Income Investors: This REIT Is on Sale</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Privia Health Group</li>
<li>在哪里找到财报电话会议记录</li>
<li>MP 材料公司在财报后股价飙升——真正原因在这里</li>
<li>每股收益计算器：如何计算 EPS</li>
<li>为什么 Palantir 的下滑可能是长期机会的铺垫</li>
<li>股息贵族的最佳名单：通过贵族指数积累财富</li>
<li>收入投资者注意：这只 REIT 正在打折出售</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UFJWQQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=PRVA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Privia Health Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Privia Health Group 吗？</h2>
</div><p>Before you consider Privia Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Privia Health Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Privia Health Group 并不在名单上。</p>
</div><p>While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Privia Health Group 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Dynamic Technology Lab Private Ltd 在 Privia Health Group, Inc.持有价值 631,000 美元的股票头寸